The Critical Medical Infrastructure Right-to-Repair Act will prevent medical device innovation by forcing manufacturers to cede intellectual property, according to an opinion piece in the Washington Times.
Aside from a potential vaccine, medical innovators, including in the medical device industry, are investing unprecedented levels of manpower and resources to help contain this pandemic. From rapid-result coronavirus tests to novel decontamination systems for personal protective equipment, these innovations are a critical pillar of support for providers and health care workers on the frontlines of this fight.
Unfortunately, while innovators are working around-the-clock to deliver life-saving solutions to patients and health care providers, some opportunistic businesses are trying to use the power of government to seize the intellectual property of these innovators for their own commercial interests.
This is government overreach at its worst and will hurt American innovation across the board.
Read the full article in the Washington Times.